
-
PLASMA & BIOTHERAPIES - 11-01-2021
CARES10 clinical trial: last patient treated in the USA
Study to assess efficacy, safety and pharmacokinetics of a 10 percent Immunoglobulin in PI patients
read more -
PLASMA & BIOTHERAPIES - 21-08-2020
First and Only US Pediatric human rabies Immune globulin Trial
Kedrion-Kamada Announce Study Met Its Primary Objective
read more -
PLASMA & BIOTHERAPIES - 20-06-2019
First patient enrolled and treated in Kedrion’s CARES10 clinical study
Phase 3 study to assess efficacy, safety and pharmacokinetics of a 10% IVIg in the treatment of adult PID patients
read more -
PLASMA & BIOTHERAPIES - 22-03-2017
Article by Prof. Farrugia and Daniela Scaramuccia published on “Biologicals”
International medical journal hosts review of contract plasma fractionation dynamics
read more
Pages
For more information please contact: pressoffice@kedrion.com